- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 12 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 21 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.3: 3 residues within 4Å:- Chain A: N.280, E.281, N.282
No protein-ligand interaction detected (PLIP)NAG-NAG.4: 4 residues within 4Å:- Chain A: N.331, Q.580, T.581, L.582
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:L.582
NAG-NAG.7: 1 residues within 4Å:- Chain A: N.616
No protein-ligand interaction detected (PLIP)NAG-NAG.8: 2 residues within 4Å:- Chain A: H.655, N.657
No protein-ligand interaction detected (PLIP)NAG-NAG.9: 3 residues within 4Å:- Chain A: N.706, G.1128
- Chain B: D.793
No protein-ligand interaction detected (PLIP)NAG-NAG.11: 3 residues within 4Å:- Chain A: N.798, S.800, Q.801
No protein-ligand interaction detected (PLIP)NAG-NAG.12: 3 residues within 4Å:- Chain A: A.703, E.1069, N.1071
No protein-ligand interaction detected (PLIP)NAG-NAG.17: 3 residues within 4Å:- Chain B: N.280, E.281, N.282
No protein-ligand interaction detected (PLIP)NAG-NAG.18: 4 residues within 4Å:- Chain B: N.331, Q.580, T.581, L.582
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:L.582
NAG-NAG.21: 1 residues within 4Å:- Chain B: N.616
No protein-ligand interaction detected (PLIP)NAG-NAG.22: 2 residues within 4Å:- Chain B: H.655, N.657
No protein-ligand interaction detected (PLIP)NAG-NAG.23: 3 residues within 4Å:- Chain B: N.706, G.1128
- Chain C: D.793
No protein-ligand interaction detected (PLIP)NAG-NAG.25: 3 residues within 4Å:- Chain B: N.798, S.800, Q.801
No protein-ligand interaction detected (PLIP)NAG-NAG.26: 3 residues within 4Å:- Chain B: A.703, E.1069, N.1071
No protein-ligand interaction detected (PLIP)NAG-NAG.31: 3 residues within 4Å:- Chain C: N.280, E.281, N.282
No protein-ligand interaction detected (PLIP)NAG-NAG.32: 4 residues within 4Å:- Chain C: N.331, Q.580, T.581, L.582
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:L.582
NAG-NAG.35: 1 residues within 4Å:- Chain C: N.616
No protein-ligand interaction detected (PLIP)NAG-NAG.36: 2 residues within 4Å:- Chain C: H.655, N.657
No protein-ligand interaction detected (PLIP)NAG-NAG.37: 3 residues within 4Å:- Chain A: D.793
- Chain C: N.706, G.1128
No protein-ligand interaction detected (PLIP)NAG-NAG.39: 3 residues within 4Å:- Chain C: N.798, S.800, Q.801
No protein-ligand interaction detected (PLIP)NAG-NAG.40: 3 residues within 4Å:- Chain C: A.703, E.1069, N.1071
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-FUC.5: 11 residues within 4Å:- Chain A: F.338, G.339, N.343
- Chain C: Y.489
- Chain D: W.47, K.59, Y.60, N.61, E.62
- Chain G: W.94, P.95
5 PLIP interactions:1 interactions with chain C, 3 interactions with chain D, 1 interactions with chain G- Hydrogen bonds: C:Y.489, D:E.62, D:E.62, D:E.62
- Hydrophobic interactions: D:K.59, G:W.94
NAG-NAG-BMA-FUC.19: 9 residues within 4Å:- Chain B: F.338, G.339, N.343
- Chain E: W.47, K.59, Y.60, E.62
- Chain H: W.94, P.95
3 PLIP interactions:2 interactions with chain E, 1 interactions with chain H- Hydrogen bonds: E:E.62, E:E.62
- Hydrophobic interactions: E:K.59, H:W.94
NAG-NAG-BMA-FUC.33: 10 residues within 4Å:- Chain B: Y.489
- Chain C: F.338, G.339, N.343
- Chain F: W.47, K.59, Y.60, E.62
- Chain I: W.94, P.95
4 PLIP interactions:1 interactions with chain B, 2 interactions with chain F, 1 interactions with chain I- Hydrogen bonds: B:Y.489, F:E.62, F:E.62
- Hydrophobic interactions: F:K.59, I:W.94
- 3 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN.10: 3 residues within 4Å:- Chain A: N.714, L.919, Q.923
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:L.919
NAG-NAG-BMA-MAN.24: 3 residues within 4Å:- Chain B: N.714, L.919, Q.923
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:L.919
NAG-NAG-BMA-MAN.38: 3 residues within 4Å:- Chain C: N.714, L.919, Q.923
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:L.919
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.43: 3 residues within 4Å:- Chain A: Y.28, N.30, N.61
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:N.30
NAG.44: 3 residues within 4Å:- Chain B: Y.28, N.30, N.61
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:N.30
NAG.45: 3 residues within 4Å:- Chain C: Y.28, N.30, N.61
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:N.30
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Errico, J.M. et al., Structural mechanism of SARS-CoV-2 neutralization by two murine antibodies targeting the RBD. Cell Rep (2021)
- Release Date
- 2021-09-29
- Peptides
- Spike glycoprotein: ABC
2H04 heavy chain: DEF
2H04 light chain: GHI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HE
IF
JG
LH
MI
N
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 12 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 21 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Errico, J.M. et al., Structural mechanism of SARS-CoV-2 neutralization by two murine antibodies targeting the RBD. Cell Rep (2021)
- Release Date
- 2021-09-29
- Peptides
- Spike glycoprotein: ABC
2H04 heavy chain: DEF
2H04 light chain: GHI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HE
IF
JG
LH
MI
N